The global market for Anti-infectious Disease Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-infectious Disease Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-infectious Disease Drugs.

The Anti-infectious Disease Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-infectious Disease Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Anti-infectious Disease Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Anti-infectious Disease Drugs Market Report

Report Metric	Details
Report Name	Anti-infectious Disease Drugs Market
CAGR	5%
Segment by Type	Antibacterial Drugs Antifungal Drugs Antiviral Drugs Antiparasitic Drugs
Segment by Application	Hospital Institute of Medicine Clinic Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Aridis Pharmaceuticals, AiCuris, Sandoz, Anhui Jingfang Medical Industry Co.,Ltd, Beijing Double-Crane Pharmaceutical Co., Ltd., Abbott, Spero Therapeutics, Adlyfe, Inc., Advanced Life Sciences Holdings, Inc., Affinium Pharmaceuticals, APP Pharmaceuticals, Aquapharm Biodiscovery, Basilea Pharmaceutica AG, Biophage Pharma, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-infectious Disease Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-infectious Disease Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Anti-infectious Disease Drugs Market report?

Ans: The main players in the Anti-infectious Disease Drugs Market are Aridis Pharmaceuticals, AiCuris, Sandoz, Anhui Jingfang Medical Industry Co.,Ltd, Beijing Double-Crane Pharmaceutical Co., Ltd., Abbott, Spero Therapeutics, Adlyfe, Inc., Advanced Life Sciences Holdings, Inc., Affinium Pharmaceuticals, APP Pharmaceuticals, Aquapharm Biodiscovery, Basilea Pharmaceutica AG, Biophage Pharma, Inc.

What are the Application segmentation covered in the Anti-infectious Disease Drugs Market report?

Ans: The Applications covered in the Anti-infectious Disease Drugs Market report are Hospital, Institute of Medicine, Clinic, Others

What are the Type segmentation covered in the Anti-infectious Disease Drugs Market report?

Ans: The Types covered in the Anti-infectious Disease Drugs Market report are Antibacterial Drugs, Antifungal Drugs, Antiviral Drugs, Antiparasitic Drugs

1 Anti-infectious Disease Drugs Market Overview

1.1 Product Definition

1.2 Anti-infectious Disease Drugs by Type

1.2.1 Global Anti-infectious Disease Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 Antibacterial Drugs

1.2.3 Antifungal Drugs

1.2.4 Antiviral Drugs

1.2.5 Antiparasitic Drugs

1.3 Anti-infectious Disease Drugs by Application

1.3.1 Global Anti-infectious Disease Drugs Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Institute of Medicine

1.3.4 Clinic

1.3.5 Others

1.4 Global Anti-infectious Disease Drugs Market Size Estimates and Forecasts

1.4.1 Global Anti-infectious Disease Drugs Revenue 2020-2031

1.4.2 Global Anti-infectious Disease Drugs Sales 2020-2031

1.4.3 Global Anti-infectious Disease Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Anti-infectious Disease Drugs Market Competition by Manufacturers

2.1 Global Anti-infectious Disease Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global Anti-infectious Disease Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Anti-infectious Disease Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Anti-infectious Disease Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Anti-infectious Disease Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Anti-infectious Disease Drugs, Product Type & Application

2.7 Global Key Manufacturers of Anti-infectious Disease Drugs, Date of Enter into This Industry

2.8 Global Anti-infectious Disease Drugs Market Competitive Situation and Trends

2.8.1 Global Anti-infectious Disease Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Anti-infectious Disease Drugs Players Market Share by Revenue

2.8.3 Global Anti-infectious Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Anti-infectious Disease Drugs Market Scenario by Region

3.1 Global Anti-infectious Disease Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Anti-infectious Disease Drugs Sales by Region: 2020-2031

3.2.1 Global Anti-infectious Disease Drugs Sales by Region: 2020-2025

3.2.2 Global Anti-infectious Disease Drugs Sales by Region: 2026-2031

3.3 Global Anti-infectious Disease Drugs Revenue by Region: 2020-2031

3.3.1 Global Anti-infectious Disease Drugs Revenue by Region: 2020-2025

3.3.2 Global Anti-infectious Disease Drugs Revenue by Region: 2026-2031

3.4 North America Anti-infectious Disease Drugs Market Facts & Figures by Country

3.4.1 North America Anti-infectious Disease Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Anti-infectious Disease Drugs Sales by Country (2020-2031)

3.4.3 North America Anti-infectious Disease Drugs Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Anti-infectious Disease Drugs Market Facts & Figures by Country

3.5.1 Europe Anti-infectious Disease Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Anti-infectious Disease Drugs Sales by Country (2020-2031)

3.5.3 Europe Anti-infectious Disease Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Anti-infectious Disease Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Anti-infectious Disease Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Anti-infectious Disease Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific Anti-infectious Disease Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Anti-infectious Disease Drugs Market Facts & Figures by Country

3.7.1 Latin America Anti-infectious Disease Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Anti-infectious Disease Drugs Sales by Country (2020-2031)

3.7.3 Latin America Anti-infectious Disease Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Anti-infectious Disease Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Anti-infectious Disease Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Anti-infectious Disease Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa Anti-infectious Disease Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Anti-infectious Disease Drugs Sales by Type (2020-2031)

4.1.1 Global Anti-infectious Disease Drugs Sales by Type (2020-2025)

4.1.2 Global Anti-infectious Disease Drugs Sales by Type (2026-2031)

4.1.3 Global Anti-infectious Disease Drugs Sales Market Share by Type (2020-2031)

4.2 Global Anti-infectious Disease Drugs Revenue by Type (2020-2031)

4.2.1 Global Anti-infectious Disease Drugs Revenue by Type (2020-2025)

4.2.2 Global Anti-infectious Disease Drugs Revenue by Type (2026-2031)

4.2.3 Global Anti-infectious Disease Drugs Revenue Market Share by Type (2020-2031)

4.3 Global Anti-infectious Disease Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global Anti-infectious Disease Drugs Sales by Application (2020-2031)

5.1.1 Global Anti-infectious Disease Drugs Sales by Application (2020-2025)

5.1.2 Global Anti-infectious Disease Drugs Sales by Application (2026-2031)

5.1.3 Global Anti-infectious Disease Drugs Sales Market Share by Application (2020-2031)

5.2 Global Anti-infectious Disease Drugs Revenue by Application (2020-2031)

5.2.1 Global Anti-infectious Disease Drugs Revenue by Application (2020-2025)

5.2.2 Global Anti-infectious Disease Drugs Revenue by Application (2026-2031)

5.2.3 Global Anti-infectious Disease Drugs Revenue Market Share by Application (2020-2031)

5.3 Global Anti-infectious Disease Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Aridis Pharmaceuticals

6.1.1 Aridis Pharmaceuticals Company Information

6.1.2 Aridis Pharmaceuticals Description and Business Overview

6.1.3 Aridis Pharmaceuticals Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Aridis Pharmaceuticals Anti-infectious Disease Drugs Product Portfolio

6.1.5 Aridis Pharmaceuticals Recent Developments/Updates

6.2 AiCuris

6.2.1 AiCuris Company Information

6.2.2 AiCuris Description and Business Overview

6.2.3 AiCuris Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 AiCuris Anti-infectious Disease Drugs Product Portfolio

6.2.5 AiCuris Recent Developments/Updates

6.3 Sandoz

6.3.1 Sandoz Company Information

6.3.2 Sandoz Description and Business Overview

6.3.3 Sandoz Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Sandoz Anti-infectious Disease Drugs Product Portfolio

6.3.5 Sandoz Recent Developments/Updates

6.4 Anhui Jingfang Medical Industry Co.,Ltd

6.4.1 Anhui Jingfang Medical Industry Co.,Ltd Company Information

6.4.2 Anhui Jingfang Medical Industry Co.,Ltd Description and Business Overview

6.4.3 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Product Portfolio

6.4.5 Anhui Jingfang Medical Industry Co.,Ltd Recent Developments/Updates

6.5 Beijing Double-Crane Pharmaceutical Co., Ltd.

6.5.1 Beijing Double-Crane Pharmaceutical Co., Ltd. Company Information

6.5.2 Beijing Double-Crane Pharmaceutical Co., Ltd. Description and Business Overview

6.5.3 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Product Portfolio

6.5.5 Beijing Double-Crane Pharmaceutical Co., Ltd. Recent Developments/Updates

6.6 Abbott

6.6.1 Abbott Company Information

6.6.2 Abbott Description and Business Overview

6.6.3 Abbott Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Abbott Anti-infectious Disease Drugs Product Portfolio

6.6.5 Abbott Recent Developments/Updates

6.7 Spero Therapeutics

6.7.1 Spero Therapeutics Company Information

6.7.2 Spero Therapeutics Description and Business Overview

6.7.3 Spero Therapeutics Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Spero Therapeutics Anti-infectious Disease Drugs Product Portfolio

6.7.5 Spero Therapeutics Recent Developments/Updates

6.8 Adlyfe, Inc.

6.8.1 Adlyfe, Inc. Company Information

6.8.2 Adlyfe, Inc. Description and Business Overview

6.8.3 Adlyfe, Inc. Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Adlyfe, Inc. Anti-infectious Disease Drugs Product Portfolio

6.8.5 Adlyfe, Inc. Recent Developments/Updates

6.9 Advanced Life Sciences Holdings, Inc.

6.9.1 Advanced Life Sciences Holdings, Inc. Company Information

6.9.2 Advanced Life Sciences Holdings, Inc. Description and Business Overview

6.9.3 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Product Portfolio

6.9.5 Advanced Life Sciences Holdings, Inc. Recent Developments/Updates

6.10 Affinium Pharmaceuticals

6.10.1 Affinium Pharmaceuticals Company Information

6.10.2 Affinium Pharmaceuticals Description and Business Overview

6.10.3 Affinium Pharmaceuticals Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Affinium Pharmaceuticals Anti-infectious Disease Drugs Product Portfolio

6.10.5 Affinium Pharmaceuticals Recent Developments/Updates

6.11 APP Pharmaceuticals

6.11.1 APP Pharmaceuticals Company Information

6.11.2 APP Pharmaceuticals Description and Business Overview

6.11.3 APP Pharmaceuticals Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.11.4 APP Pharmaceuticals Anti-infectious Disease Drugs Product Portfolio

6.11.5 APP Pharmaceuticals Recent Developments/Updates

6.12 Aquapharm Biodiscovery

6.12.1 Aquapharm Biodiscovery Company Information

6.12.2 Aquapharm Biodiscovery Description and Business Overview

6.12.3 Aquapharm Biodiscovery Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Aquapharm Biodiscovery Anti-infectious Disease Drugs Product Portfolio

6.12.5 Aquapharm Biodiscovery Recent Developments/Updates

6.13 Basilea Pharmaceutica AG

6.13.1 Basilea Pharmaceutica AG Company Information

6.13.2 Basilea Pharmaceutica AG Description and Business Overview

6.13.3 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Product Portfolio

6.13.5 Basilea Pharmaceutica AG Recent Developments/Updates

6.14 Biophage Pharma, Inc.

6.14.1 Biophage Pharma, Inc. Company Information

6.14.2 Biophage Pharma, Inc. Description and Business Overview

6.14.3 Biophage Pharma, Inc. Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Biophage Pharma, Inc. Anti-infectious Disease Drugs Product Portfolio

6.14.5 Biophage Pharma, Inc. Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Anti-infectious Disease Drugs Industry Chain Analysis

7.2 Anti-infectious Disease Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Anti-infectious Disease Drugs Production Mode & Process Analysis

7.4 Anti-infectious Disease Drugs Sales and Marketing

7.4.1 Anti-infectious Disease Drugs Sales Channels

7.4.2 Anti-infectious Disease Drugs Distributors

7.5 Anti-infectious Disease Drugs Customer Analysis

8 Anti-infectious Disease Drugs Market Dynamics

8.1 Anti-infectious Disease Drugs Industry Trends

8.2 Anti-infectious Disease Drugs Market Drivers

8.3 Anti-infectious Disease Drugs Market Challenges

8.4 Anti-infectious Disease Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Aridis Pharmaceuticals

AiCuris

Sandoz Inc

Beijing Double Crane Pharmaceutical Co., Ltd.

Abbott

Spero Therapeutics

App pharmaceuticals

Basilea Pharmaceutica AG

Anhui Jingfang Medical Industry Co.,Ltd

Adlyfe, Inc.

Advanced Life Sciences Holdings, Inc.

Affinium Pharmaceuticals

Aquapharm Biodiscovery

Biophage Pharma, Inc.

List of Tables

Table 1. Global Anti-infectious Disease Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Anti-infectious Disease Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Anti-infectious Disease Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global Anti-infectious Disease Drugs Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Anti-infectious Disease Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Anti-infectious Disease Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Anti-infectious Disease Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Anti-infectious Disease Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Anti-infectious Disease Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Anti-infectious Disease Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Anti-infectious Disease Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Anti-infectious Disease Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Anti-infectious Disease Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-infectious Disease Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Anti-infectious Disease Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Anti-infectious Disease Drugs Sales by Region (2020-2025) & (K Units)

Table 18. Global Anti-infectious Disease Drugs Sales Market Share by Region (2020-2025)

Table 19. Global Anti-infectious Disease Drugs Sales by Region (2026-2031) & (K Units)

Table 20. Global Anti-infectious Disease Drugs Sales Market Share by Region (2026-2031)

Table 21. Global Anti-infectious Disease Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Anti-infectious Disease Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global Anti-infectious Disease Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Anti-infectious Disease Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America Anti-infectious Disease Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Anti-infectious Disease Drugs Sales by Country (2020-2025) & (K Units)

Table 27. North America Anti-infectious Disease Drugs Sales by Country (2026-2031) & (K Units)

Table 28. North America Anti-infectious Disease Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Anti-infectious Disease Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Anti-infectious Disease Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Anti-infectious Disease Drugs Sales by Country (2020-2025) & (K Units)

Table 32. Europe Anti-infectious Disease Drugs Sales by Country (2026-2031) & (K Units)

Table 33. Europe Anti-infectious Disease Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Anti-infectious Disease Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Anti-infectious Disease Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Anti-infectious Disease Drugs Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Anti-infectious Disease Drugs Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Anti-infectious Disease Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Anti-infectious Disease Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Anti-infectious Disease Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Anti-infectious Disease Drugs Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Anti-infectious Disease Drugs Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Anti-infectious Disease Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Anti-infectious Disease Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Anti-infectious Disease Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Anti-infectious Disease Drugs Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Anti-infectious Disease Drugs Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Anti-infectious Disease Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Anti-infectious Disease Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Anti-infectious Disease Drugs Sales (K Units) by Type (2020-2025)

Table 51. Global Anti-infectious Disease Drugs Sales (K Units) by Type (2026-2031)

Table 52. Global Anti-infectious Disease Drugs Sales Market Share by Type (2020-2025)

Table 53. Global Anti-infectious Disease Drugs Sales Market Share by Type (2026-2031)

Table 54. Global Anti-infectious Disease Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Anti-infectious Disease Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Anti-infectious Disease Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global Anti-infectious Disease Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global Anti-infectious Disease Drugs Price (US$/Unit) by Type (2020-2025)

Table 59. Global Anti-infectious Disease Drugs Price (US$/Unit) by Type (2026-2031)

Table 60. Global Anti-infectious Disease Drugs Sales (K Units) by Application (2020-2025)

Table 61. Global Anti-infectious Disease Drugs Sales (K Units) by Application (2026-2031)

Table 62. Global Anti-infectious Disease Drugs Sales Market Share by Application (2020-2025)

Table 63. Global Anti-infectious Disease Drugs Sales Market Share by Application (2026-2031)

Table 64. Global Anti-infectious Disease Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Anti-infectious Disease Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Anti-infectious Disease Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global Anti-infectious Disease Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global Anti-infectious Disease Drugs Price (US$/Unit) by Application (2020-2025)

Table 69. Global Anti-infectious Disease Drugs Price (US$/Unit) by Application (2026-2031)

Table 70. Aridis Pharmaceuticals Company Information

Table 71. Aridis Pharmaceuticals Description and Business Overview

Table 72. Aridis Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Aridis Pharmaceuticals Anti-infectious Disease Drugs Product

Table 74. Aridis Pharmaceuticals Recent Developments/Updates

Table 75. AiCuris Company Information

Table 76. AiCuris Description and Business Overview

Table 77. AiCuris Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. AiCuris Anti-infectious Disease Drugs Product

Table 79. AiCuris Recent Developments/Updates

Table 80. Sandoz Company Information

Table 81. Sandoz Description and Business Overview

Table 82. Sandoz Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Sandoz Anti-infectious Disease Drugs Product

Table 84. Sandoz Recent Developments/Updates

Table 85. Anhui Jingfang Medical Industry Co.,Ltd Company Information

Table 86. Anhui Jingfang Medical Industry Co.,Ltd Description and Business Overview

Table 87. Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Product

Table 89. Anhui Jingfang Medical Industry Co.,Ltd Recent Developments/Updates

Table 90. Beijing Double-Crane Pharmaceutical Co., Ltd. Company Information

Table 91. Beijing Double-Crane Pharmaceutical Co., Ltd. Description and Business Overview

Table 92. Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Product

Table 94. Beijing Double-Crane Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 95. Abbott Company Information

Table 96. Abbott Description and Business Overview

Table 97. Abbott Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Abbott Anti-infectious Disease Drugs Product

Table 99. Abbott Recent Developments/Updates

Table 100. Spero Therapeutics Company Information

Table 101. Spero Therapeutics Description and Business Overview

Table 102. Spero Therapeutics Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Spero Therapeutics Anti-infectious Disease Drugs Product

Table 104. Spero Therapeutics Recent Developments/Updates

Table 105. Adlyfe, Inc. Company Information

Table 106. Adlyfe, Inc. Description and Business Overview

Table 107. Adlyfe, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Adlyfe, Inc. Anti-infectious Disease Drugs Product

Table 109. Adlyfe, Inc. Recent Developments/Updates

Table 110. Advanced Life Sciences Holdings, Inc. Company Information

Table 111. Advanced Life Sciences Holdings, Inc. Description and Business Overview

Table 112. Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Product

Table 114. Advanced Life Sciences Holdings, Inc. Recent Developments/Updates

Table 115. Affinium Pharmaceuticals Company Information

Table 116. Affinium Pharmaceuticals Description and Business Overview

Table 117. Affinium Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Affinium Pharmaceuticals Anti-infectious Disease Drugs Product

Table 119. Affinium Pharmaceuticals Recent Developments/Updates

Table 120. APP Pharmaceuticals Company Information

Table 121. APP Pharmaceuticals Description and Business Overview

Table 122. APP Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. APP Pharmaceuticals Anti-infectious Disease Drugs Product

Table 124. APP Pharmaceuticals Recent Developments/Updates

Table 125. Aquapharm Biodiscovery Company Information

Table 126. Aquapharm Biodiscovery Description and Business Overview

Table 127. Aquapharm Biodiscovery Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Aquapharm Biodiscovery Anti-infectious Disease Drugs Product

Table 129. Aquapharm Biodiscovery Recent Developments/Updates

Table 130. Basilea Pharmaceutica AG Company Information

Table 131. Basilea Pharmaceutica AG Description and Business Overview

Table 132. Basilea Pharmaceutica AG Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Basilea Pharmaceutica AG Anti-infectious Disease Drugs Product

Table 134. Basilea Pharmaceutica AG Recent Developments/Updates

Table 135. Biophage Pharma, Inc. Company Information

Table 136. Biophage Pharma, Inc. Description and Business Overview

Table 137. Biophage Pharma, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. Biophage Pharma, Inc. Anti-infectious Disease Drugs Product

Table 139. Biophage Pharma, Inc. Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Anti-infectious Disease Drugs Distributors List

Table 143. Anti-infectious Disease Drugs Customers List

Table 144. Anti-infectious Disease Drugs Market Trends

Table 145. Anti-infectious Disease Drugs Market Drivers

Table 146. Anti-infectious Disease Drugs Market Challenges

Table 147. Anti-infectious Disease Drugs Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of Anti-infectious Disease Drugs

Figure 2. Global Anti-infectious Disease Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Anti-infectious Disease Drugs Market Share by Type: 2024 & 2031

Figure 4. Antibacterial Drugs Product Picture

Figure 5. Antifungal Drugs Product Picture

Figure 6. Antiviral Drugs Product Picture

Figure 7. Antiparasitic Drugs Product Picture

Figure 8. Global Anti-infectious Disease Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Anti-infectious Disease Drugs Market Share by Application: 2024 & 2031

Figure 10. Hospital

Figure 11. Institute of Medicine

Figure 12. Clinic

Figure 13. Others

Figure 14. Global Anti-infectious Disease Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Anti-infectious Disease Drugs Market Size (2020-2031) & (US$ Million)

Figure 16. Global Anti-infectious Disease Drugs Sales (2020-2031) & (K Units)

Figure 17. Global Anti-infectious Disease Drugs Average Price (US$/Unit) & (2020-2031)

Figure 18. Anti-infectious Disease Drugs Report Years Considered

Figure 19. Anti-infectious Disease Drugs Sales Share by Manufacturers in 2024

Figure 20. Global Anti-infectious Disease Drugs Revenue Share by Manufacturers in 2024

Figure 21. Global 5 and 10 Largest Anti-infectious Disease Drugs Players: Market Share by Revenue in Anti-infectious Disease Drugs in 2024

Figure 22. Anti-infectious Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. Global Anti-infectious Disease Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 24. North America Anti-infectious Disease Drugs Sales Market Share by Country (2020-2031)

Figure 25. North America Anti-infectious Disease Drugs Revenue Market Share by Country (2020-2031)

Figure 26. United States Anti-infectious Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Canada Anti-infectious Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Europe Anti-infectious Disease Drugs Sales Market Share by Country (2020-2031)

Figure 29. Europe Anti-infectious Disease Drugs Revenue Market Share by Country (2020-2031)

Figure 30. Germany Anti-infectious Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. France Anti-infectious Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. U.K. Anti-infectious Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Italy Anti-infectious Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Russia Anti-infectious Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Asia Pacific Anti-infectious Disease Drugs Sales Market Share by Region (2020-2031)

Figure 36. Asia Pacific Anti-infectious Disease Drugs Revenue Market Share by Region (2020-2031)

Figure 37. China Anti-infectious Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Japan Anti-infectious Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. South Korea Anti-infectious Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. India Anti-infectious Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Australia Anti-infectious Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. China Taiwan Anti-infectious Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Indonesia Anti-infectious Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Thailand Anti-infectious Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Malaysia Anti-infectious Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Anti-infectious Disease Drugs Sales Market Share by Country (2020-2031)

Figure 47. Latin America Anti-infectious Disease Drugs Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Anti-infectious Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Anti-infectious Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Anti-infectious Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa Anti-infectious Disease Drugs Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Anti-infectious Disease Drugs Revenue Market Share by Country (2020-2031)

Figure 53. Turkey Anti-infectious Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Anti-infectious Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. UAE Anti-infectious Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of Anti-infectious Disease Drugs by Type (2020-2031)

Figure 57. Global Revenue Market Share of Anti-infectious Disease Drugs by Type (2020-2031)

Figure 58. Global Anti-infectious Disease Drugs Price (US$/Unit) by Type (2020-2031)

Figure 59. Global Sales Market Share of Anti-infectious Disease Drugs by Application (2020-2031)

Figure 60. Global Revenue Market Share of Anti-infectious Disease Drugs by Application (2020-2031)

Figure 61. Global Anti-infectious Disease Drugs Price (US$/Unit) by Application (2020-2031)

Figure 62. Anti-infectious Disease Drugs Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions